News & Insights
Sort By
Insights 1 result
Insights
|November 9, 2017
The Most Important New Privacy Law in a Generation: The GDPR
If you have any questions regarding the matters covered in this client alert, you may contact the following GD attorneys:
Events 1 result
Events
|March 21, 2023
Webinar: Generative AI Latest Developments, Legal Risks and Best Practices
Gunderson Dettmer hosts the Generative AI: Latest Developments, Legal Risks and Best Practices webinar, the first of its Generative AI series.
Client News 33 Results
Client News
|February 21, 2025
Hims & Hers Announces Acquisition of Peptide Facility in California
Hims & Hers announces its acquisition of a California-based peptide facility
Client News
|February 19, 2025
Hims & Hers announces its acquisition of Sigmund NJ LLC, dba Trybe Labs
Client News
|December 11, 2024
Forbes 14th Annual 30 Under 30 List Recognizes 27 Individuals Across 20 Gunderson Dettmer Clients
27 individuals across 20 Gunderson Dettmer clients recognized in the 14th annual Forbes 30 under 30 North America list
Firm News 6 Results
Firm News
|April 25, 2022
Gunderson Dettmer Recognized in 2022 Mergers and Acquisitions Top Middle-Market Deals of the Year
Gunderson Dettmer was recognized as a winner in the 15th Annual Mergers and Acquisitions Top Middle-Market Deals of the Year for its representation of Foresight Sports in its acquisition by Vista Outdoor and The Athletic in its acquisition by The New York Times, two out of the thirteen winning deals for the categories Media and Consumer Products and Outdoor Recreation.
Firm News
|August 14, 2020
Gina Marek, a partner in the firm’s Silicon Valley office, has been named the Northern California head of the Licensing, Strategic Partnering & Commercial Transactions practice group.
Firm News
|September 14, 2018
Gunderson Dettmer was recognized for a “Finance & Transactional Impact Deal of the Year” at the 2018 Euromoney LMG Life Sciences Awards. Gunderson Dettmer won the award for its representation of ARMO BioSciences, a late-stage immuno-oncology company, in its $1.6 billion sale to Eli Lilly & Company. Gunderson Dettmer also congratulates Lilly for being shortlisted for the Financial & Corporate In-House Team of the Year award at the same event.